Zhenxi Chen – Trademark Portfolio

Entity Type: 01

Zhenxi Chen owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as UMAXES, EMARALY, and EVALIAZ. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 20 (Furniture) and Class 14 (Jewelry). Headquartered in Guangxi.

No. 75, Changtang Village,

Dongxiang Town, Wuxuan County,

Guangxi 545900 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EVALIAZ
EVALIAZ
Registered 2024
EMARALY
EMARALY
Registered 2024
UMAXES
UMAXES
Registered 2024

Trademark Classifications

Zhenxi Chen's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

34
Smokers Articles (1 filing)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does Zhenxi Chen have?

Zhenxi Chen has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Zhenxi Chen file in?

Zhenxi Chen files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 14 (Jewelry), Class 34 (Smokers Articles). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Zhenxi Chen's most well-known trademarks?

Zhenxi Chen's registered trademark portfolio includes well-known marks such as UMAXES, EMARALY, and EVALIAZ. These are among 3 currently registered trademarks in the portfolio.

What is Zhenxi Chen's trademark registration success rate?

Zhenxi Chen has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.